Messenger RNA (mRNA) vaccines are one of the biggest medical breakthroughs of recent years. It was first introduced during ...

Billions of mRNA vaccine doses administered globally confirm their safety and effectiveness against infectious diseases, ...

Moderna hit a 52-week high after it unveiled a strategy to expand its mRNA platform beyond vaccines into oncology, autoimmune ...

Moderna surges 33.5% after the company outlines plans to expand its mRNA platform beyond vaccines into oncology, autoimmune diseases and cell therapies.

FDA advisors have recommended Moderna's MFLUSIVA, paving the way for the world's first approved mRNA flu vaccine for older ...

The technology that gave the world mRNA COVID vaccines is being tested in a variety of new ways, and emerging research ...

FDA panel backs 1st mRNA flu vaccine, recommending Moderna's mFlusiva for adults 50 and older with conditions for 65+ adults.

This GEN Spotlight on RNA Therapeutics brings you three interlinked sessions that feature outstanding researchers exploring various aspects of RNA biology and therapeutics.

A Food and Drug Administration advisory panel on Thursday recommended the approval of Moderna’s mRNA-based flu shot for older adults.

Nadine and David Lipworth have devoted their lives to finding treatment that will restore the daughter they knew.

An FDA advisory committee voted unanimously on June 18 to recommend that a messenger RNA-based influenza vaccine at the center of a recent change of heart by the FDA be approved for older adults.In ...

All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over.